Table 2

Expression of GLT and IGH in jejunal mucosa biopsies and peripheral blood of H and IBS-D participants

Jejunal mucosaBlood
GLTH (n=10)IBS-D (n=12–16)p Value H (n=10)IBS-D (n=9)p Value
μGLT1.01±0.211.32±0.280.002†*1.00±0.221.30±0.210.007
γ3GLT0.99±0.351.74±0.760.002†*0.99±0.440.91±0.260.643
γ1GLT0.80 (0.40–1.80)1.90 (1.10–2.90)0.001*1.06±0.201.36±0.300.032
αGLT1.00±0.711.72±0.970.2021.00±0.620.80±0.220.624
γ2GLT0.99±0.201.54±0.150.002*1.00±0.571.33±0.340.223
γ4GLT1.00±0.511.69±1.260.2410.98 (0.60–1.40)2.30 (0.60–8.20)0.194
εGLT1.01±0.500.98±0.460.9041.00±0.131.04±0.200.639
IGHH (n=14)IBS (n=16)p ValueH (n=10)IBS (n=9)p Value
IGHM1.01±0.201.02±0.270.8271.00±0.210.99±0.150.934
IGHG31.01±0.381.37±0.460.023†0.98 (0.52–1.45)0.56 (0.49–1.9)0.347
IGHG10.98±0.271.51±0.39<0.001†**1.00±0.160.93±0.140.345
IGHA1.00±0.151.09±0.230.2051.00±0.290.85±0.150.195
IGHG21.00±0.311.29±0.420.0430.99±0.180.80±0.120.019
IGHG41.00 (0.40–1.60)1.55 (1.00–2.10)<0.001†**0.99±0.271.04±0.130.595
IGHE1.01±0.331.42±0.420.009†**0.99±0.330.74±0.190.065
  • GAPDH was used as a house-keeping gene. GLT and IGH bands were quantified by densitometric analysis and the expression of each transcript was calculated with respect to the corresponding GAPDH value. PCR products were identified by size, gel-extracted and sequenced to confirm their identity (data not shown).

  • p Values considered significant are shown in bold. p Value adjusted (false discovery rate): *<0.05; **<0.01.

  • †Differential expression between atopic and non-atopic subjects in the IBS-D group (figure 3 and see online supplementary figure 2).

  • GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GLT, germline transcript; H, healthy subjects; IBS-D, diarrhoea-predominant IBS; IGH, Ig heavy chain.